Skip to main content
. 2022 Nov 12;29(11):8626–8637. doi: 10.3390/curroncol29110680

Figure 3.

Figure 3

Trends of prescribing specialty of novel hormonal agent (NHA) initiators stratified by chemotherapy status in ENZ-era. (A) Trends of prescribing specialty among post-chemotherapy patients. (B) Trends of prescribing specialty among chemotherapy-naïve patients.